Companies to ensure lower GST on existing Covid drug stock

Downward change in GST rates should reflect on MRP National Pharmaceutical Pricing Authority (NPPA) has asked manufacturers and marketing companies related with drugs, formulations and medical devices to revise the Maximum Retail Prices (MRP) based on lower Goods & Services Tax (GST). More importantly, it has asked companies to ensure compliance of lower tax on existing stock. The GST Council,…